The Changing Management of Multiple Sclerosis-Dimethyl Fumarate (Tecfidera) for MS
April 22nd 2013Patients with relapsing-remitting multiple sclerosis experience an accumulation of central nervous system damage and associated cognitive and physical disability progression. With the widespread use of disease modifying therapies, health plans have experienced improved clinical outcomes for MS together with increasing associated pharmacy-related expenses.
Read More
Navigators to Play Critical Role in Healthcare Exchange Marketplaces
April 18th 2013A recent press release from the Centers for Medicare & Medicaid Services (CMS) revealed the group's intention to recruit Navigators in assisting consumers with the new healthcare exchanges, especially as October enrollment dates quickly approach.
Read More